Post hoc analysis of data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial on the effects of three years of raloxifene treatment on glycemic control and cardiovascular disease risk factors in women with and without type 2 diabetes

✍ Scribed by Elizabeth Barrett-Connor; Kristine E. Ensrud; Kristine Harper; Timothy M. Mason; Andreas Sashegyi; Kathryn A. Krueger; Pamela W. Anderson

• Book ID: 117321409
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 876 KB
• Volume: 25
• Category: Article
• ISSN: 0149-2918
• DOI: 10.1016/s0149-2918(03)80114-5